A B S Financial Services, Inc. ABS Financial Services. Inc. Financial Planning Consultants. Taxes - Consultants & Representatives. Tax Return Preparation
4811 Lebanon Road, Suite 102, Hermitage, TN 37076 6158838828, 6158836520
Dan Robinson President
TIMETRONIX INC. Parking Stations & Garages - Equipment & Supplies. Time Recorders
629 Central Ave., London, ON N5W 3P7 5196458463
Dan Robinson Branch Manager
Commercial Lighting Products Ltd Lighting Systems & Equipment
5919 90 St NW, Edmonton, AB T6E 6C2 7804680999, 7804667718
The present disclosure relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present disclosure relates to gene fusions as diagnostic markers and clinical targets for breast cancer.
- Ann Arbor MI, US Dan ROBINSON - Ann Arbor MI, US Marcin CIESLIK - Ann Arbor MI, US
International Classification:
C07K 16/28 A61P 35/00 C12Q 1/6886
Abstract:
Provided herein are compositions and methods for treating cancer. In particular, provided herein are compositions, methods, and uses of targeted therapy to treat cancer (e.g., prostate cancer) in subjects with CDK12 mutations.
Systems And Methods For Determining A Treatment Course Of Action
- Ann Arbor MI, US Dan Robinson - Ann Arbor MI, US
International Classification:
C12Q 1/6886 C07K 14/705 G01N 33/574 C07K 14/72
Abstract:
The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their association with responsiveness to estrogen therapies for cancer.
Systems And Methods For Determining A Treatment Course Of Action
The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their association with responsiveness to estrogen therapies for cancer.
- Ann Arbor MI, US Dan Robinson - Ann Arbor MI, US
International Classification:
C12Q 1/68 G01N 33/574
US Classification:
435 611, 536 2431, 536 2433, 5303897, 435 723
Abstract:
The present disclosure relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present disclosure relates to gene fusions as diagnostic markers and clinical targets for cancer.
- Ann Arbor MI, US Dan Robinson - Ann Arbor MI, US
International Classification:
C12Q 1/68 G01N 33/569
US Classification:
435 611, 435 71
Abstract:
Provided herein are kits, compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to recurrent gene fusions as diagnostic markers and clinical targets for hemangiopericytoma.